QNTM Class B Quantum Biopharma Ltd. - Class B Subordinate Voting Shares
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Mar 26, 2026
$3.44
· of 52w range
· above low
· to high
$2.0752w low
$18.8752w high
your badges
52W Range
$2–$19
Analyst Rating
BUY
Price Target
$12
P/E
·
ROE
·
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
QNTM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$3.44
52W Range
$2–$19
QNTM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Aug. 15, 2024 | 1-for-65 | Reverse |
| Oct. 16, 2019 | 1-for-201 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue·2019-12-31 → 2019-12-31
Free Cash Flow·2019-12-31 → 2024-12-31
Net margin·2019-12-31 → 2019-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | QNTM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 1.15Y avg ≈2.6 | ≈2.6 | · | · | |
| Quick Ratio | 0.35Y avg ≈1.6 | ≈1.6 | · | · | |
| Interest Coverage | -96.85Y avg ≈-255.3 | ≈-255.3 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-14.8%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| Dec. 31, 2025 | $-0.71 | — | — | |
| Dec. 31, 2020 | $-22.04 | $-92.82 | 76.3% | |
| Sept. 30, 2020 | $-89.05 | $-47.40 | -87.9% | |
| June 30, 2020 | $-43.55 | $-73.59 | 40.8% | |
| Dec. 31, 2019 | $-177.45 | $-94.15 | -88.5% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $257.1K | |
| Cost of Revenue | · | · | · | · | · | · | $2M | |
| Gross Profit | · | · | · | · | · | · | $-2M | |
| R&D Expense | $3M | $6M | $4M | $7M | $6M | $8M | $0 | |
| SG&A Expense | $9M | $9M | $9M | $14M | $16M | $10M | $8M | |
| Operating Income | $-15M | $-16M | $-24M | $-27M | $-34M | $-31M | $-22M | |
| Interest Expense | $158.1K | $33.0K | $299 | $63.4K | $69.4K | $235.6K | $155.3K | |
| Interest Income | · | · | $568.9K | $183.0K | · | · | · | |
| Net Income | · | · | · | $-24M | $-35M | $-32M | $-39M | |
| Shares (Basic) | · | · | · | 38,732,381 | 34,945,210 | 12,043,961 | · | |
| Shares (Diluted) | · | 1,136,922 | 609,056 | 595,883 | 34,945,210 | 12,043,961 | 7,056,245 | |
| EBITDA | $-15M | $490.6K | $3M | $-23M | $-30M | $-27M | $-34M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $6M | $3M | $17M | $35M | $18M | $6M | |
| Receivables | · | · | · | $374.4K | $501.0K | $161.3K | $2M | |
| Inventory | $52.1K | $117.2K | $0 | · | · | $0 | $709.4K | |
| Current Assets | $6M | $12M | $11M | $18M | $46M | $27M | $9M | |
| PP&E (Net) | $67.0K | $76.9K | $87.6K | $105.7K | $0 | $0 | $9M | |
| Intangibles | $5M | $5M | $5M | $12M | $16M | $13M | $17M | |
| Total Assets | $11M | $17M | $17M | $38M | $63M | $42M | $43M | |
| Accounts Payable | $4M | $4M | $4M | $7M | $8M | $4M | $3M | |
| Current Liabilities | $6M | $7M | $5M | $8M | $9M | $6M | $7M | |
| Total Liabilities | $6M | $7M | $5M | $8M | $9M | $6M | $7M | |
| Retained Earnings | $-198M | $-172M | $-158M | $-144M | $-126M | $-91M | $-59M | |
| Stockholders' Equity | $7M | $11M | $13M | $31M | $54M | $36M | $36M |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $545.8K | $490.6K | $3M | $5M | $4M | $4M | $2M | |
| Other Non-cash | · | · | · | $-9M | $10M | $9M | $31M | |
| Operating Cash Flow | $-8M | $-7M | $-11M | $-28M | $-21M | $-19M | $-14M | |
| CapEx | · | $0 | $0 | $114.0K | $0 | $0 | $534.1K | |
| Investing Cash Flow | $-2M | $-2M | $-269.6K | $12M | $269.0K | $7M | $-230.9K | |
| Financing Cash Flow | $6M | $12M | $-3M | $-2M | $38M | $24M | $4M | |
| Free Cash Flow | · | $-7M | $-11M | $-28M | · | · | $-19M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | -936.2% | |
| Operating Margin | · | · | · | · | · | · | -14263.0% | |
| Net Margin | · | · | · | · | · | · | -20230.8% | |
| EBITDA Margin | · | · | · | · | · | · | -13039.1% | |
| ROA | · | · | · | -46.6% | -67.2% | -74.7% | -106.9% | |
| ROE | · | · | · | -55.8% | -78.0% | -87.6% | -120.1% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.8 | 2.4 | 2.3 | 5.3 | 4.8 | 1.3 | |
| Quick Ratio | 0.3 | 0.9 | 0.6 | 2.2 | 4.1 | 3.2 | 1.1 | |
| Interest Coverage | -96.8 | · | · | -183.0 | -486.2 | -130.3 | -177.6 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | 4.2 | |
| Receivables Turnover | · | · | · | · | · | · | 0.2 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue / Share | · | · | · | · | · | · | $0.04 | |
| Cash Flow / Share | · | $-6.05 | $-0.27 | $-0.73 | $-0.59 | $-1.59 | $-2.58 |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | $257.1K | |
| Net Income TTM | · | · | · | $-24M | $-35M | $-32M | $-39M |
No quarterly filings for QNTM
We don't have SEC filings for this ticker yet.
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | · | · | · | $-24M | $-35M |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.8 | 2.4 | 2.3 | 5.3 |
| Quick Ratio | 0.3 | 0.9 | 0.6 | 2.2 | 4.1 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | · | $-7M | $-11M | $-28M | · |
Institutional owners (13F) 26 filers · $1.5M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
26
Value held
$1.5M
New positions
4
Exited positions
3
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 4 (-3 vs prior Q) | 3 (-2 vs prior Q) | 8 (+1 vs prior Q) | 4 (+3 vs prior Q) | +161K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| AdvisorShares Investments LLC | $736,902 | 203,564 | 49.04% | Shares |
| JANE STREET GROUP, LLC | $175,045 | 48,355 | 11.65% | Shares |
| Platform Technology Partners | $148,840 | 41,116 | 9.91% | Shares |
| UBS Group AG | $120,926 | 33,405 | 8.05% | Shares |
| Steward Partners Investment Advisory, LLC | $100,929 | 27,881 | 6.72% | Shares |
| CITADEL ADVISORS LLC | $57,424 | 15,863 | 3.82% | Shares |
| Marex Group Ltd | $48,638 | 13,436 | 3.24% | Shares |
| Mariner, LLC | $36,200 | 10,000 | 2.41% | Shares |
| LANARK FINANCIAL, INC. | $25,340 | 7,000 | 1.69% | Shares |
| OSAIC HOLDINGS, INC. | $22,787 | 6,295 | 1.52% | Shares |
| Global Retirement Partners, LLC | $10,860 | 3,000 | 0.72% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $4,594 | 1,209 | 0.31% | Shares |
| Farther Finance Advisors, LLC | $3,620 | 1,000 | 0.24% | Shares |
| Atlantic Union Bankshares Corp | $3,620 | 1,000 | 0.24% | Shares |
| MORGAN STANLEY | $2,172 | 600 | 0.14% | Shares |
| ROYAL BANK OF CANADA | $2,000 | 446 | 0.13% | Shares |
| WELLS FARGO & COMPANY/MN | $907 | 250 | 0.06% | Shares |
| Cetera Trust Company, N.A | $905 | 250 | 0.06% | Shares |
| Federation des caisses Desjardins du Quebec | $334 | 93 | 0.02% | Shares |
| SBI Securities Co., Ltd. | $286 | 79 | 0.02% | Shares |
| GROUP ONE TRADING LLC | $123 | 34 | 0.01% | Shares |
| Rockefeller Capital Management L.P. | $109 | 30 | 0.01% | Shares |
| Activest Wealth Management | $54 | 15 | 0.00% | Shares |
| TD Waterhouse Canada Inc. | $20 | 6 | 0.00% | Shares |
| Purpose Unlimited Inc. | $4 | 1 | 0.00% | Shares |
| CITIGROUP INC | $4 | 1 | 0.00% | Shares |
Activists & 5%+ owners 4 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Malone Wealth Ventures LLC ×4 filings | June 23, 2025 | 0.00% | Amendment | Passive investment | SEC |
| Dr. Raza Bokhari (2) | April 11, 2022 | · | Initial filing | Passive investment | SEC |
| First Republic Capital Corporation, Fortius Research and Trading Corporation, Anthony Durkacz, Richard Goldstein, Andrew Durkacz, Gloria Durkacz, Xorax Family Trust, Legacy Family Trust, Zeeshan Saeed, Rehan Saeed, Zachary Dutton | April 1, 2021 | · | Initial filing | Board campaign | SEC |
| Dr. Raza Bokhari ×2 filings | Feb. 22, 2021 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
QNTM Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
BUY
Median target
$12.25
+256.0%
2 28.6%
Strong Buy
4 57.1%
Buy
1 14.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
1 analysts · 2026-10-04Mean target $12.25 +256.0%
Low$12.25
Mean$12.25
High$12.25
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Mar 26, 2026